期刊文献+

固化条件对膜控型缓释微丸释药性能的影响 被引量:4

Effects of Curing Conditions on Dissolution Behaviors of Film Coated Sustained Release Pellets
原文传递
导出
摘要 以盐酸左旋沙丁胺醇为模型药物,丙烯酸树脂水分散体Eudragit NE30D为包衣材料,采用流化床包衣法制备缓释微丸。以释放度和释药性能稳定性为评价指标,考察了不同固化条件对微丸的影响。结果表明,提高固化温度和加湿固化均有助于促进衣膜愈合。60℃固化12 h和60℃、相对湿度(RH)75%固化6 h所得微丸的体外释药均符合设计要求。上述两种固化条件下所得微丸在常温贮存条件下的释药稳定性良好,在较激烈贮存条件下的释药性能则大多发生显著变化,仅后一条件固化微丸敞开于25℃、RH 60%环境中释药性能基本稳定。 The sustained-release pellets loaded with levalbuterol hydrochloride were prepared by fluid-bed coating method with Eudragit NE30D as the coating material. The effects of different curing conditions on pellets were evaluated with in vitro release and stability of release behaviors as indexes. The results showed that both temperature and humidity contributed to the film curing process. Pellets cured under the conditions of 60℃for 12 h and 60 ℃, RH 75% for 6 h showed desired release profile. For both pellets, release behaviors were stable when stored under room temperature; however significant changes were observed when conditions turned harsh; under storage condition of 25 ℃, RH 60 %, only pellets prepared by the latter treatment could remain stable.
作者 奚泉 金方
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第1期25-29,共5页 Chinese Journal of Pharmaceuticals
基金 国家“重大新药创制”科技重大专项(2009ZX09301-007) 上海市科学技术委员会生物医药重点科技攻关项目(09431901500)
关键词 盐酸左旋沙丁胺醇 微丸 EUDRAGIT NE 30D 固化 释放度 释药性能稳定性 levalbuterol hydrochloride pellet Eudragit NE 30D curing release stability of release
  • 相关文献

参考文献3

  • 1Williams RO 3rd, Liu J. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate [J]. Eur J Pharm Biopharm, 2000, 49 (3) : 243-252.
  • 2Slattery D, Wong SW, Colin AA. Levalbuterol hydrochloride [J]. PedPulm, 2002,33 (2) : 151-157.
  • 3Wu C, McGinity JW. Influence of relative humidity on the mechanical and drug release properties of theophylline pellets coated with an acrylic polymer containing methylparaben as a non-traditional plasticizer [J]. Eur J Pharm Biopharm, 2000, 50 (2) : 277-284.

同被引文献37

  • 1钱厚海,王幼珍.氟代喹诺酮类抗菌药简介[J].人民军医,1993,36(3):75-76. 被引量:1
  • 2王俊,周寅,曹志娟,赖顺果,裴元英.计算机辅助成像分析法在微丸圆整度评价中的应用[J].中国药学杂志,2005,40(7):529-531. 被引量:4
  • 3潘晓娴,唐英春.喹诺酮类抗菌药耐药机制研究进展[J].中国抗感染化疗杂志,2005,5(3):187-191. 被引量:20
  • 4张安阳,范田园.多单元胃漂浮给药系统研究进展[J].国际药学研究杂志,2007,34(4):274-279. 被引量:13
  • 5Ramachandran S, Shaheedha SM,Thimmumgan G, et 8]. Floating con- trolled drug delivery system of famotidine loaded hollow microspheres (mieroballoons) in the stomach[ J ]. Curr Drug Deliv,2010,7 ( 1 ) :93- 7.
  • 6Hamdani J, Moes A J, Amighi IC Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization [J]. Int J Pharm,2006,322(1-2) :96-103.
  • 7Kotreka UK, Adeyeye MC. Gastroretentive floating drug-delivery sys- tems:a critical review[J]. Crit Rev Ther Drug Carrier Syst,2011,28 ( 1 ) :47-99.
  • 8Lunio R,Sawicki W. Influence of acry]ic esters and methacyrlic esters on flotation d pellets and release rate of verapamil hydrochloride[J] Acta Pol Phann,2006,63 (1) :69-74.
  • 9Amrutkar PP, Chaudhari PD, Patil SB. Desi and in vitro evaluation of mu|tipm'ficulate floating drug delivery system of zo|pidem tartarat [J]. Colloids SurfB Biointerfaces,2012,89:182-7.
  • 10OTH M,FRANZ M,TIMMERMANS J,et al.The bilayer floating capsule:a stomach-directed drug delivery system for misoprostol[J].Pharm Res,1992,9(3):298-302.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部